$2.13
Acurx Pharmaceuticals is a biotechnology business based in the US. Acurx Pharmaceuticals shares (ACXP) are listed on the NASDAQ and all prices are listed in US Dollars. Acurx Pharmaceuticals employs 4 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Acurx Pharmaceuticals LLC stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Acurx Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ACXP. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Acurx Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Acurx Pharmaceuticals stock price (NASDAQ: ACXP)
Use our graph to track the performance of ACXP stocks over time.Acurx Pharmaceuticals shares at a glance
Latest market close | $2.13 |
---|---|
52-week range | $1.17 - $8.82 |
50-day moving average | $2.18 |
200-day moving average | $2.75 |
Wall St. target price | $11.26 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.16 |
Is it a good time to buy Acurx Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Acurx Pharmaceuticals price performance over time
Historical closes compared with the close of $2.13 from 2024-09-05
1 week (2024-08-30) | -3.18% |
---|---|
1 month (2024-08-06) | 4.41% |
3 months (2024-06-06) | -10.13% |
6 months (2024-03-06) | -29.00% |
1 year (2023-09-06) | 21.02% |
---|---|
2 years (2022-09-06) | -39.66% |
3 years (2021-09-03) | 5.78 |
5 years (2019-09-02) | N/A |
Acurx Pharmaceuticals financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -132.22% |
Return on equity TTM | -346.94% |
Profit margin | 0% |
Book value | $0.21 |
Market Capitalization | $35.7 million |
TTM: trailing 12 months
Acurx Pharmaceuticals share dividends
We're not expecting Acurx Pharmaceuticals to pay a dividend over the next 12 months.
You may also wish to consider:
- Pfizer (PFE.US) (5.79% forward annual dividend yield)
- Novartis AG ADR (NVS.US) (3.12% forward annual dividend yield)
- Merck-and-Company (MRK.US) (2.6% forward annual dividend yield)
Acurx Pharmaceuticals share price volatility
Over the last 12 months, Acurx Pharmaceuticals's shares have ranged in value from as little as $1.17 up to $8.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Acurx Pharmaceuticals's is -1.716. This would suggest that Acurx Pharmaceuticals's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Acurx Pharmaceuticals has bucked the trend.
To put Acurx Pharmaceuticals's beta into context you can compare it against those of similar companies.
- Pfizer (PFE.US): 0.633
- Novartis AG ADR (NVS.US): 0.492
- Merck-and-Company (MRK.US): 0.389
Acurx Pharmaceuticals overview
Acurx Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York. .
Frequently asked questions
nullWhat percentage of Acurx Pharmaceuticals is owned by insiders or institutions?
Currently 14.802% of Acurx Pharmaceuticals shares are held by insiders and 11.886% by institutions. How many people work for Acurx Pharmaceuticals?
Latest data suggests 4 work at Acurx Pharmaceuticals. When does the fiscal year end for Acurx Pharmaceuticals?
Acurx Pharmaceuticals's fiscal year ends in December. Where is Acurx Pharmaceuticals based?
Acurx Pharmaceuticals's address is: 259 Liberty Avenue, Staten Island, NY, United States, 10305 What is Acurx Pharmaceuticals's ISIN number?
Acurx Pharmaceuticals's international securities identification number is: US00510M1045
More guides on Finder
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
6 stocks like Nvidia you need to consider
Advanced Micro Devices (AMD), Intel Corporation (INTC) and Qualcomm Inc (QCOM) are top stocks like Nvidia. See our full list here.
-
GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
-
Public vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
10 E*TRADE competitors worth your time
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
-
Charles Schwab vs. Fidelity
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question